NCT04287439

Brief Summary

Patients with painful diabethic peripheral neuropathy will be entered.. Participants will be randomized to one of three study arms: Arm 1: relaxatio; Arm 2:meditation Arm 3: Attention matched control Hypothesis: Progressive muscle relaxation and mindfullness meditation will decrease severity of neuropathc pain and fatigue and improve quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 8, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 17, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 17, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 24, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 27, 2020

Completed
Last Updated

February 27, 2020

Status Verified

February 1, 2020

Enrollment Period

1.4 years

First QC Date

February 24, 2020

Last Update Submit

February 25, 2020

Conditions

Keywords

Fatigue, meditation, diabetic neuropathy, relaxation, quality of life.

Outcome Measures

Primary Outcomes (1)

  • Change in pain severity

    Pain severity will be measured based on patient report by a visual analog scale. Higher score means increase in pain severity.

    Baseline measurements, at the end of 12th week and two weeks after the completion of the interventions

Secondary Outcomes (2)

  • Change in fatigue severity

    Baseline measurements, at the end of 12th week and two weeks after the completion of the interventions

  • Change in Quality of life status

    baseline measurements, at the end of 12th week and two weeks after the completion of the interventions

Study Arms (3)

Relaxation

EXPERIMENTAL

Patients will receive a training session for progressive muscle relaxation exercise. They will practice it daily at their home during 12 weeks. Patients will be called daily to ensure that patients perform the intervention according to the study protocol, and to assess their study-adherence.

Behavioral: Progressive muscle relaxation

Meditation

EXPERIMENTAL

Patients will receive a training session for minfullness meditation They will practice it daily at their home during 12 weeks. Patients will be called daily to ensure that patients perform the intervention according to the study protocol, and to assess their study-adherence.

Behavioral: Mindfulness meditation

Attention matched control group

ACTIVE COMPARATOR

Patients will receive a training session focusing on the anatomy and physiological functions of the pancreas, general information about type 2 diabetes including signs, complication, and treatment methods.

Other: Attention matched control

Interventions

Patients will receive a training session for progressive muscle relaxation exercise They will practice it daily at their home during 12 weeks. Patients will be called daily to ensure that patients perform the intervention according to the study protocol, and to assess their study-adherence.

Relaxation

Patients will receive a training session for mindfulness meditation. They will practice it daily at their home during 12 weeks. Patients will be called daily to ensure that patients perform the intervention according to the study protocol, and to assess their study-adherence.

Meditation

Patients will receive a training session focusing on focusing on the anatomy and physiological functions of the pancreas, general information about type 2 diabetes including signs, complication, and treatment methods

Attention matched control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • being diagnosed with painful diabethic peripheral neuropathy ,
  • being at least primary school graduates,
  • not using any other complementary or integrative therapy during the study period

You may not qualify if:

  • neuropathy history due to any other causes such as megaloblastic anemia, fibromyalgia, autoimmune diseases, hypothyroidism, and lumbar disc hernia
  • having end-stage of renal failure, chronic obstructive pulmonary disease, advanced cardiac failure, musculoskeletal disorders or depression
  • having a diabetic foot ulcer or amputation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara University Medical Faculty Ibni Sina Hospital Endocrinology Outpatient Unit

Ankara, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetic NeuropathiesFatigue

Interventions

Autogenic TrainingMindfulness

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

HypnosisMind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and ActivitiesCognitive Behavioral TherapyBehavior Therapy

Study Officials

  • Nur Izgu, PhD

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

February 24, 2020

First Posted

February 27, 2020

Study Start

June 8, 2018

Primary Completion

November 17, 2019

Study Completion

November 17, 2019

Last Updated

February 27, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations